热休克蛋白90（Hsp90）的天然产物抑制剂：药物研发的潜在先导物
Natural product inhibitors of Hsp90: potential leads for drug discovery.
作者信息
Amolins M W, Blagg B S J
机构信息
Department of Medicinal Chemistry, The University of Kansas, 1251 Wescoe Hall Drive, Malott 4070, Lawrence, Kansas 66045-7563, USA.
出版信息
Mini Rev Med Chem. 2009 Feb;9(2):140-52. doi: 10.2174/138955709787316056.
Abstract
Heat shock protein 90 has emerged as a promising target for the treatment of cancer and neurodegenerative diseases. This review summarizes recent advancements towards the development of natural products as they pertain to the biological and chemical understanding of this molecular chaperone.
摘要
热休克蛋白90已成为治疗癌症和神经退行性疾病的一个有前景的靶点。本综述总结了天然产物开发方面的最新进展，这些进展与对这种分子伴侣的生物学和化学理解有关。
相似文献
1
Natural product inhibitors of Hsp90: potential leads for drug discovery.热休克蛋白90（Hsp90）的天然产物抑制剂：药物研发的潜在先导物
Mini Rev Med Chem. 2009 Feb;9(2):140-52. doi: 10.2174/138955709787316056.
2
Small molecule inhibitors targeting heat shock protein 90: An updated review.靶向热休克蛋白 90 的小分子抑制剂：最新综述。
Eur J Med Chem. 2024 Sep 5;275:116562. doi: 10.1016/j.ejmech.2024.116562. Epub 2024 Jun 3.
3
Natural heat shock protein 90 inhibitors in cancer and inflammation.天然热休克蛋白 90 抑制剂在癌症和炎症中的作用。
Eur J Med Chem. 2020 Mar 1;189:112063. doi: 10.1016/j.ejmech.2020.112063. Epub 2020 Jan 11.
4
Natural Product Inspired N-Terminal Hsp90 Inhibitors: From Bench to Bedside?受天然产物启发的N端Hsp90抑制剂：从实验室到临床？
Med Res Rev. 2016 Jan;36(1):92-118. doi: 10.1002/med.21351. Epub 2015 May 25.
5
Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.靶向热休克蛋白 90（Hsp90）的天然产物：格尔德霉素，癌症治疗的典范。
Nat Prod Rep. 2013 Oct 11;30(10):1299-323. doi: 10.1039/c3np70012g. Epub 2013 Aug 12.
6
Drug Design, Synthesis and In Vitro Evaluation of Substituted Benzofurans as Hsp90 Inhibitors.作为Hsp90抑制剂的取代苯并呋喃类药物的设计、合成及体外评价
Med Chem. 2018;14(1):44-52. doi: 10.2174/1573406413666170623085534.
7
Using natural product inhibitors to validate Hsp90 as a molecular target in cancer.利用天然产物抑制剂验证热休克蛋白90（Hsp90）作为癌症的分子靶点。
Curr Top Med Chem. 2006;6(11):1163-71. doi: 10.2174/156802606777811979.
8
Purine-scaffold Hsp90 inhibitors.嘌呤支架 HSP90 抑制剂。
Curr Top Med Chem. 2009;9(15):1436-46. doi: 10.2174/156802609789895737.
9
Recent update on discovery and development of Hsp90 inhibitors as senolytic agents.最近关于 HSP90 抑制剂作为衰老细胞溶解剂的发现和开发的最新进展。
Int J Biol Macromol. 2020 Oct 15;161:1086-1098. doi: 10.1016/j.ijbiomac.2020.06.115. Epub 2020 Jun 16.
10
Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.天然化合物作为潜在的乳腺癌 Hsp90 抑制剂：基于药效团的分子模拟研究。
Comput Biol Chem. 2019 Dec;83:107113. doi: 10.1016/j.compbiolchem.2019.107113. Epub 2019 Sep 5.
引用本文的文献
1
In Vitro Release and In Vivo Study of Recombinant TGF-β and EGCG from Dual Self-Cross-Linked Alginate-Di-Aldehyde Injectable Hydrogel for the Repair of a Degenerated Intervertebral Disc in a Rat Tail.用于修复大鼠尾部退变椎间盘的双自交联海藻酸钠-二醛可注射水凝胶中重组转化生长因子-β和表没食子儿茶素没食子酸酯的体外释放及体内研究
Gels. 2025 Jul 22;11(8):565. doi: 10.3390/gels11080565.
2
Michael Acceptors as Anti-Cancer Compounds: Coincidence or Causality?迈克尔受体作为抗癌化合物：巧合还是必然？
Int J Mol Sci. 2024 Jun 1;25(11):6099. doi: 10.3390/ijms25116099.
3
Evaluation of the Anti-Metastatic Effect of Foeniculum Vulgare on the Protein Expression of HSP 70 & 90 in Balb/c Mice with 4t1 Model of Breast Cancer.评价小茴香对 4t1 乳腺癌模型 Balb/c 小鼠 HSP70 和 HSP90 蛋白表达的抗转移作用。
Asian Pac J Cancer Prev. 2023 Mar 1;24(3):833-840. doi: 10.31557/APJCP.2023.24.3.833.
4
Natural Products Targeting Hsp90 for a Concurrent Strategy in Glioblastoma and Neurodegeneration.靶向热休克蛋白90用于胶质母细胞瘤和神经退行性疾病联合治疗策略的天然产物
Metabolites. 2022 Nov 21;12(11):1153. doi: 10.3390/metabo12111153.
5
Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1)-ones Bis-Heterocycles as Potential Inhibitors of the Protein Folding Machinery Hsp90.3-(杂芳基)喹啉-2(1)-酮双杂环作为蛋白质折叠机制Hsp90潜在抑制剂的合成及生物活性
Molecules. 2022 Jan 9;27(2):412. doi: 10.3390/molecules27020412.
6
Natural compounds in the regulation of proteostatic pathways: An invincible artillery against stress, ageing, and diseases.天然化合物在蛋白质稳态途径调控中的作用：对抗应激、衰老和疾病的无敌武器。
Acta Pharm Sin B. 2021 Oct;11(10):2995-3014. doi: 10.1016/j.apsb.2021.01.006. Epub 2021 Jan 7.
7
Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.细胞表面 GRP94 作为单克隆抗体癌症治疗的新型新兴治疗靶点。
Cells. 2021 Mar 17;10(3):670. doi: 10.3390/cells10030670.
8
Pharmacological Properties of Chalcones: A Review of Preclinical Including Molecular Mechanisms and Clinical Evidence.查耳酮的药理特性：临床前研究综述，包括分子机制和临床证据
Front Pharmacol. 2021 Jan 18;11:592654. doi: 10.3389/fphar.2020.592654. eCollection 2020.
9
National Institute on Aging Workshop: Repurposing Drugs or Dietary Supplements for Their Senolytic or Senomorphic Effects: Considerations for Clinical Trials.美国国家老龄化研究所研讨会：重新利用药物或膳食补充剂以实现其衰老或衰老相关的作用：临床试验的考虑因素。
J Gerontol A Biol Sci Med Sci. 2021 May 22;76(6):1144-1152. doi: 10.1093/gerona/glab028.
10
A Chemical Biology Approach to the Chaperome in Cancer-HSP90 and Beyond.一种化学生物学方法研究癌症中的伴侣蛋白组——HSP90 及其以外的伴侣蛋白。
Cold Spring Harb Perspect Biol. 2020 Apr 1;12(4):a034116. doi: 10.1101/cshperspect.a034116.
本文引用的文献
1
The exploration of macrocycles for drug discovery--an underexploited structural class.用于药物发现的大环化合物探索——一类未被充分利用的结构类型。
Nat Rev Drug Discov. 2008 Jul;7(7):608-24. doi: 10.1038/nrd2590.
2
Heat shock protein 90 inhibition in lung cancer.肺癌中的热休克蛋白90抑制作用
J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S152-9. doi: 10.1097/JTO.0b013e318174ea3a.
3
Total synthesis of the Hsp90 inhibitor geldanamycin.热休克蛋白90（Hsp90）抑制剂格尔德霉素的全合成。
Org Lett. 2008 Jun 19;10(12):2477-9. doi: 10.1021/ol800749w. Epub 2008 May 20.
4
Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin.Bcr-Abl/Hsp90蛋白复合物的破坏：新生霉素抑制Bcr-Abl阳性人白血病母细胞的一种可能机制。
Leukemia. 2008 Jul;22(7):1402-9. doi: 10.1038/leu.2008.89. Epub 2008 Apr 17.
5
Recent Advances in the Study of hsp90 Structure and Mechanism of Action.hsp90 结构与作用机制研究的新进展
Trends Endocrinol Metab. 1998 Aug;9(6):238-43. doi: 10.1016/s1043-2760(98)00060-5.
6
Molecular characterization of macbecin as an Hsp90 inhibitor.作为一种热休克蛋白90（Hsp90）抑制剂的马贝西菌素的分子特征
J Med Chem. 2008 May 8;51(9):2853-7. doi: 10.1021/jm701558c. Epub 2008 Mar 22.
7
Designed TPR modules as novel anticancer agents.设计TPR模块作为新型抗癌剂。
ACS Chem Biol. 2008 Mar 20;3(3):161-6. doi: 10.1021/cb700260z.
8
Proteomics of breast cancer: the quest for markers and therapeutic targets.乳腺癌蛋白质组学：寻找标志物和治疗靶点
J Proteome Res. 2008 Apr;7(4):1403-11. doi: 10.1021/pr700870c. Epub 2008 Feb 27.
9
Development of novobiocin analogues that manifest anti-proliferative activity against several cancer cell lines.表现出对多种癌细胞系具有抗增殖活性的新生霉素类似物的开发。
J Org Chem. 2008 Mar 21;73(6):2130-7. doi: 10.1021/jo702191a. Epub 2008 Feb 23.
10
The Hsp90 molecular chaperone: an open and shut case for treatment.热休克蛋白90（Hsp90）分子伴侣：治疗的一个成败关键案例。
Biochem J. 2008 Mar 15;410(3):439-53. doi: 10.1042/BJ20071640.
Zotero 插件